Kubin Klaus, Sodeck Gottfried H, Teufelsbauer H, Nowatschka Bernd, Kretschmer Georg, Lammer Johannes, Schoder Maria
Department of Cardiovascular and Interventional Radiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.
Cardiovasc Intervent Radiol. 2008 May-Jun;31(3):496-503. doi: 10.1007/s00270-007-9253-9. Epub 2008 Jan 8.
As an alternative to open aneurysm repair, emergency endovascular aortic repair (EVAR) has emerged as a promising technique for ruptured abdominal aortic aneurysm (rAAA) within the last decade. The aim of this retrospective study is to present early and late outcomes of patients treated with EVAR for rAAA. Twenty-two patients (5 women, 17 men; mean age, 74 years) underwent EVAR for rAAA between November 2000 and April 2006. Diagnostic multislice computed tomography angiography was performed prior to stent-graft repair to evaluate anatomical characteristics and for follow-up examinations. Periprocedural patient characteristics and technical settings were evaluated. Mortality rates, hospital stay, and early and late complications, within a mean follow-up time of 744 +/- 480 days, were also assessed. Eight of 22 patients were hemodynamically unstable at admission. Stent-graft insertion was successful in all patients. The total early complication rate was 54%, resulting in a 30-day mortality rate of 23%. The median intensive care unit stay was 2 days (range, 2-48 days), and the median hospital stay was 16 days (range, 9-210 days). During the follow-up period, three patients suffered from stent-graft-related complications. The overall mortality rate in our study group was 36%. EVAR is an acceptable, minimally invasive treatment option in patients with acute rAAA, independent of the patient's general condition. Short- and long-term outcomes are definitely comparable to those with open surgical repair procedures.
作为开放性动脉瘤修复术的替代方法,急诊血管腔内主动脉修复术(EVAR)在过去十年中已成为治疗破裂腹主动脉瘤(rAAA)的一种有前景的技术。这项回顾性研究的目的是呈现接受EVAR治疗的rAAA患者的早期和晚期结果。2000年11月至2006年4月期间,22例患者(5例女性,17例男性;平均年龄74岁)接受了rAAA的EVAR治疗。在进行支架移植物修复之前,进行了诊断性多层计算机断层扫描血管造影,以评估解剖特征并用于随访检查。评估了围手术期患者特征和技术设置。还评估了平均随访时间为744±480天内的死亡率、住院时间以及早期和晚期并发症。22例患者中有8例入院时血流动力学不稳定。所有患者的支架移植物植入均成功。早期并发症总发生率为54%,导致30天死亡率为23%。重症监护病房的中位住院时间为2天(范围2 - 48天),中位住院时间为16天(范围9 - 210天)。在随访期间,3例患者出现与支架移植物相关的并发症。我们研究组的总死亡率为36%。对于急性rAAA患者,EVAR是一种可接受的微创治疗选择,与患者的一般状况无关。短期和长期结果肯定与开放性手术修复程序相当。